COVID-19 and Calcineurin Inhibitors: Should They Get Left Out in the Storm?
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
COVID-19 and Calcineurin Inhibitors: Should They Get Left Out in the Storm?
Authors
Keywords
-
Journal
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Volume 31, Issue 6, Pages 1145-1146
Publisher
American Society of Nephrology (ASN)
Online
2020-04-21
DOI
10.1681/asn.2020030348
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury
- (2020) Clark D Russell et al. LANCET
- Successful recovery of COVID‐19 pneumonia in a renal transplant recipient with long‐term immunosuppression
- (2020) Lan Zhu et al. AMERICAN JOURNAL OF TRANSPLANTATION
- COVID-19 in kidney transplant recipients
- (2020) Ilaria Gandolfini et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Case report of COVID-19 in a kidney transplant recipient: Does immunosuppression alter the clinical presentation?
- (2020) Elena Guillen et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?
- (2020) Andrew I Ritchie et al. LANCET
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- Coronaviruses and Immunosuppressed Patients: The Facts During the Third Epidemic
- (2020) Lorenzo D’Antiga LIVER TRANSPLANTATION
- Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome
- (2019) Chelsea Kotch et al. Expert Review of Clinical Immunology
- CAR T cell–induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade
- (2018) Theodoros Giavridis et al. NATURE MEDICINE
- Recurrent hepatitis C virus infection post liver transplantation: impact of choice of calcineurin inhibitor
- (2013) Christophe Duvoux et al. TRANSPLANT INTERNATIONAL
- Suppression of Coronavirus Replication by Cyclophilin Inhibitors
- (2013) Yoshikazu Tanaka et al. Viruses-Basel
- Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506
- (2012) Javier Carbajo-Lozoya et al. VIRUS RESEARCH
- Cyclosporin A inhibits the replication of diverse coronaviruses
- (2011) A. H. de Wilde et al. JOURNAL OF GENERAL VIROLOGY
- The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors
- (2011) Susanne Pfefferle et al. PLoS Pathogens
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started